|
|
Expression of serum hepatocyte growth factor in patients with hypertension and its relationship with the vascular endothelial function |
JIN Peng LI Wei LI Tao LIU Hong-yu YUAN Guo-liang MA Cheng-bin |
Dpartment of Cardiology,Traditional Chinese Medical Hospital of Shuyang County in Jiangsu Province,Shuyang 223600,China |
|
|
Abstract Objective To investigate the expression of serum hepatocyte growth factor in patients with hypertension and its relationship with the vascular endothelial function.Methods 60 patients of hypertensive in our hospital from October 2013 to December 2014 were selected.They were divided into A group(n=21),B group(n=27)and C group(n=12)according to the level of blood pressure grade,and selected 30 cases of healthy people for physical examinees as the control group,baseline index and serum liver cell growth factor(HGF),plasma endothelin(ET)and plasma nitric oxide(NO) level of the three groups of patients were compared,and the correlation between HGF and ET and NO were analyzed. Results There were no statistical significant differences on subjects of gender,age,BMⅠ,FBG,TG etc of the groups(P>0.05).There were significant differences on serum HGF,ET and NO levels between hypertensive patients groups and the control group(P<0.05);HGF and ET increased with the increase of blood pressure,NO decreased with blood pressure increased,all indexes of C group had significant difference with A group and B group;HGF and NO of A group had statistical significant differences with B group(P<0.05).Spearman correlation analysis showed that the HGF had significant positive correlation with ET(r=0.69,P<0.05),and there was significant negative correlation between HGF and NO(r= 0.60,P<0.05).Conclusion There is a significant correlation between the degree of HGF and blood pressure level and body impaired endothelial function levels in patients with hypertension,which can be used as a new index reflects the degree of impaired endothelial function in essential hypertension patients.
|
|
|
|
|
[1] |
张兆.人软骨糖蛋白与老年高血压合并代谢综合征患者血管内皮的关系[J].中国综合临床,2014,30(5):496-499.
|
[2] |
王晓林,王庸晋,荣书玲,等.早期肝细胞生长因子转基因治疗对肺动脉高压大鼠细胞因子表达及肺血管和右心室重塑的影响[J].中华结核和呼吸杂志,2014,37(6):427-432.
|
[3] |
马东宇,王邦宁,胡泽平,等.肝细胞生长因子联合缬沙坦对自发性高血压大鼠心肌纤维化的影响[J].安徽医科大学学报,2013,48(10):1159-1163.
|
[4] |
张鹏,欧阳松云,孙培宗,等.NPPV联合降压药物对老年OSAHS合并高血压患者血清HGF水平及血压的影响[J].第三军医大学学报,2013,35(7):688-689.
|
[5] |
李奕宏,金梅花,于爽,等.关于高血压患者血清HGF、sⅠCAM-1水平的研究[J].心血管康复医学杂志,2012,21(4):345-348.
|
[6] |
鲍勇,王邦宁,胡泽平,等.肝细胞生长因子对自发性高血压大鼠心肌细胞凋亡的影响[J].安徽医科大学学报,2012,47(8):915-919.
|
[7] |
李亚楠,王瑞英.血清肝细胞生长因子与高血压患者合并急性冠脉综合征的相关性[J].中国心血管病研究,2010,8(12):912-914.
|
[8] |
钱倩倩,王邦宁,胡泽平,等.肝细胞生长因子联合缬沙坦对自发性高血压大鼠心肌细胞凋亡的影响[J].中国临床保健杂志,2014,17(3):284-287.
|
[9] |
王邦宁,江洁,郑慧,等.血管内皮功能及颈动脉内膜中层厚度与高血压室间隔厚度的关系[J].中国循环杂志,2014,29(Z1):142.
|
[10] |
杨琼,俞文萍,袁利月.原发性高血压患者血清对诊治高血压肾病的临床价值[J].放射免疫学杂志,2012,25(1):115.
|
[11] |
任江华.清脑降压片治疗高血压(肝阳上亢证)的临床疗效及对血管内皮功能的影响[J].中国实验方剂学杂志,2012,18(24):327-330.
|
[12] |
于安石.1、2级高血压1、2级患者血管内皮功能及厄贝沙坦对其影响的研究[D].长春:吉林大学,2011.
|
[13] |
Hu ZP,Bao Y,Chen BN,et al.Effects of recombinant adenovirus hepatcotyte growth factor gene on myocardial remodelinginspontaneouslyhypertensiverats[J].JCardiovasePharmacol Ther,2013,18(5):476-480.
|
[14] |
陈路,方红城,张志杰,等.血脂康对高血压合并高血脂患者血管内皮功能的影响[J].中国医药导报,2011,8(24):72-74.
|
[15] |
王邦宁,胡泽平,陈大年,等.高血压患者血肝细胞生长因子与血管内皮功能的关系及干预研究[J].中华高血压杂志,2007,15(3):219-222.
|
[16] |
王静,牟建军,任洁,等.青年高血压血管内皮功能损伤及早期动脉硬化改变[J].中华预防医学杂志,2012,46(1):50-52.
|
|
|
|